By: Andrew Francis
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is -97.21% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $14.08 in the current 52-week trading range.
Andrew Francis is a journalist whose work has appeared in publications such as Squawka, Hackerlap, PLOS, and Worthing Herald. While he does not have a specific focus, his articles primarily cover financial topics, including stock market analysis, institutional investments, and volatility in various companies.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Andrew Francis focuses on investment analysis and data, particularly in the stock market. His coverage includes topics such as stock analysis, volatility, institutional investors, and stock forecasts. Given this focus, he is likely to be interested in relevant insights from financial analysts or industry experts.
Since Andrew’s articles are heavily based on data and investment analysis, he may be receptive to pitches providing unique datasets or proprietary research that can support his analyses. Additionally, pitching finance professionals who can offer deep insights into specific stocks or market trends may resonate with him.
Although no specific geographic focus is mentioned for Andrew's coverage area, it would be beneficial to tailor pitches with a global perspective given the international nature of financial markets.
This information evolves through artificial intelligence and human feedback. Improve this profile .